NASDAQ: PALI
Palisade Bio Inc Stock Ownership - Who owns Palisade Bio?

Insider buying vs selling

Have Palisade Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John David FinleyCEO CFO2026-02-123,896$1.75
$6.82kSell
Mitchell Lawrence JonesChief Medical Officer2026-02-121,989$1.75
$3.48kSell
Donald Allen WilliamsDirector2026-01-165,000$1.67
$8.36kBuy
Donald Allen WilliamsDirector2026-01-095,000$1.88
$9.40kBuy

1 of 1

PALI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PALI insiders and whales buy or sell their stock.

PALI Shareholders

What type of owners hold Palisade Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC7.26%12,050,000$23.62MInstitution
Commodore Capital LP6.90%11,445,000$22.43MInstitution
Janus Henderson Group PLC6.35%10,540,334$20.66MInstitution
Point72 Asset Management LP6.33%10,495,252$20.57MInstitution
Octagon Capital Advisors LP5.77%9,567,898$18.75MInstitution
Ra Capital Management LP4.29%7,124,116$13.96MInstitution
Ameriprise Financial Inc4.17%6,911,237$13.55MInstitution
Eversept Partners LP3.25%5,391,548$10.57MInstitution
Franklin Resources Inc3.07%5,092,562$9.98MInstitution
Boxer Capital Management LLC2.89%4,799,875$9.41MInstitution

1 of 3

PALI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PALI81.91%5.00%Net BuyingNet Buying
SRZN30.39%69.61%Net BuyingNet Buying
CLYM65.37%13.15%Net BuyingNet Selling
NAGE18.63%81.37%Net Buying
AUTL52.34%0.53%

Palisade Bio Stock Ownership FAQ

Who owns Palisade Bio?

Palisade Bio (NASDAQ: PALI) is owned by 81.91% institutional shareholders, 5.00% Palisade Bio insiders, and 13.09% retail investors. Richard Garr is the largest individual Palisade Bio shareholder, owning 1.99M shares representing 1.20% of the company. Richard Garr's Palisade Bio shares are currently valued at $3.97M.

If you're new to stock investing, here's how to buy Palisade Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.